Clorox (NYSE:CLX) Price Target Cut to $155.00 by Analysts at Citigroup

Clorox (NYSE:CLX) had its price target decreased by equities research analysts at Citigroup from $165.00 to $155.00 in a research note issued on Tuesday, Benzinga reports. The firm currently has a “neutral” rating on the stock. Citigroup’s target price would indicate a potential upside of 10.30% from the company’s previous close.

A number of other equities analysts also recently weighed in on CLX. UBS Group lifted their target price on shares of Clorox from $145.00 to $170.00 and gave the stock a “neutral” rating in a research note on Friday, February 2nd. Jefferies Financial Group raised shares of Clorox from an “underperform” rating to a “hold” rating and set a $145.00 target price for the company in a research note on Tuesday, March 26th. Morgan Stanley reissued an “equal weight” rating and set a $160.00 target price on shares of Clorox in a research note on Tuesday, March 26th. The Goldman Sachs Group began coverage on shares of Clorox in a research note on Friday, March 1st. They issued a “sell” rating and a $140.00 price target for the company. Finally, Barclays decreased their price target on shares of Clorox from $148.00 to $136.00 and set an “underweight” rating for the company in a research note on Wednesday, April 10th. Four research analysts have rated the stock with a sell rating and twelve have given a hold rating to the company’s stock. According to MarketBeat, Clorox currently has an average rating of “Hold” and an average price target of $148.50.

Clorox Trading Down 1.0 %

Shares of NYSE CLX opened at $140.53 on Tuesday. The company has a debt-to-equity ratio of 11.37, a quick ratio of 0.57 and a current ratio of 0.89. Clorox has a 52-week low of $114.68 and a 52-week high of $178.21. The firm has a 50 day moving average price of $150.92 and a two-hundred day moving average price of $141.60. The stock has a market cap of $17.44 billion, a P/E ratio of 223.07, a price-to-earnings-growth ratio of 2.21 and a beta of 0.43.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Thursday, February 1st. The company reported $2.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $1.08. Clorox had a net margin of 1.09% and a return on equity of 319.41%. The firm had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $1.80 billion. During the same period in the prior year, the company posted $0.98 EPS. The company’s revenue was up 16.0% on a year-over-year basis. As a group, equities analysts forecast that Clorox will post 5.52 EPS for the current year.

Institutional Trading of Clorox

Several hedge funds and other institutional investors have recently modified their holdings of CLX. Point72 Asset Management L.P. bought a new stake in shares of Clorox in the fourth quarter valued at approximately $144,844,000. Norges Bank bought a new stake in Clorox during the 4th quarter worth approximately $128,382,000. Parsifal Capital Management LP bought a new stake in Clorox during the 4th quarter worth approximately $128,245,000. Confluence Investment Management LLC bought a new stake in Clorox during the 1st quarter worth approximately $135,630,000. Finally, Imprint Wealth LLC increased its holdings in Clorox by 16,986.8% during the 2nd quarter. Imprint Wealth LLC now owns 551,392 shares of the company’s stock worth $55,139,000 after acquiring an additional 548,165 shares during the period. Institutional investors own 78.53% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.